article thumbnail

Takeda picks up 2nd FDA-approved indication for immune globulin treatment HyQvia

Fierce Pharma

It is the second indication for HyQvia, which was first endorsed in 2014. The FDA has approved Takeda's HyQvia as a maintenance therapy for CIDP.

article thumbnail

Company profile: NeoImmuneTech

pharmaphorum

Amplifying and reinvigorating persistent T cell immunity has become a much-needed path to enhance anti-tumor efficacy. T cells are known to mediate anti-tumor immune responses. For that reason, they have become the key target of immune checkpoint therapies, like PD-(L)1 agents. Creation: Jan. Areas of expertise: Immuno-Oncology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Can you take Zyrtec while pregnant?

The Checkup by Singlecare

Being pregnant doesn’t make you immune from allergies—and, in some cases, many find that their allergy symptoms actually get worse during pregnancy. A 2014 review of studies summarizes this uncertainty, noting that some studies suggest it can help while others have been unable to confirm a link. Getting acupuncture.

FDA 114
article thumbnail

Advancing cell therapies – ?? T cells and the combination factor

European Pharmaceutical Review

Our work is establishing whether it is possible to use allogeneic innate immune cells from a healthy donor to support the immune system of a person with cancer in combatting the condition. T cells are the first line of defence in the immune system to eradicate diseases. such as a chimeric antigen receptor (CAR). In response, ??

article thumbnail

Navigating Life’s Challenges: A Pharmacist’s Transformative Journey of Dedication and Compassion

Pharmacy Is Right For Me

Commencing her journey towards becoming a pharmacist at Rosalind Franklin University of Medicine and Science in 2014, she initially hesitated about working in a community pharmacy setting.

article thumbnail

Capricor preps phase 3 for Duchenne cell therapy as it seeks a partner

pharmaphorum

CAP-1002 consists of donor cardiosphere-derived cells (CDCs) given by intravenous infusion once every three months that is thought to modulate the immune system and regenerate skeletal and cardiac muscle cells. The post Capricor preps phase 3 for Duchenne cell therapy as it seeks a partner appeared first on.

FDA 93
article thumbnail

The 5 Stages of Hashimoto’s Thyroiditis

The Thyroid Pharmacist

This means that our immune system recognizes the thyroid gland as a foreign invader and begins to attack it, eventually leading to the destruction of our thyroid tissue. Left unbalanced, the immune system may go on to attack different parts of the body, leading to the development of other autoimmune conditions. Hashimoto’s Stages.